Servatus, based in Queensland since 2012, specializes in developing biopharmaceuticals for autoimmune and inflammatory diseases. We enhance therapeutic proteins to improve treatment efficacy for conditions like rheumatoid arthritis and psoriasis, and develop microbial biotherapeutics targeting diseases such as IBD and infections like C. diff. Utilizing innovative bacterial strains and engineered proteins, we hold several patents for our advanced treatments.
